HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
The HDL hypothesis stating that simply raising HDL cholesterol (HDL-C) may produce cardiovascular benefits has been questioned recently based on several randomized clinical trials using CETP inhibitors or niacin to raise HDL-C levels. However extensive pre-clinical data support the vascular protect...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2015-09-01
|
| Colección: | Frontiers in Pharmacology |
| Materias: | |
| Acceso en línea: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00187/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|